Founded in 2014 by orthopedic surgeon Steven Goldberg, MD, Catalyst has set ourselves apart with an unwavering dedication to make shoulder replacements less invasive, with fewer complications and a more natural-feeling shoulder after surgery. Whether through total shoulder replacements, reverse shoulder arthroplasty, or other innovative procedures, we strive to advance techniques and devices for orthopedic surgery to maximize outcomes for patients, surgeons and the broader healthcare system.
PURPOSEFULLY DESIGNED™
We’re advancing the world of shoulder arthroplasty.
Experience what sets us apart.
DR. STEVEN GOLDBERG
OUR VISION
To be the best pure play shoulder company that sets new standards in shoulder surgery.
OUR MISSION
To design innovative products and solutions that continually improve shoulder replacement outcomes.
- Products based on years of proven research and clinical experience
- Precise and consistent implant placement
- Streamlined surgical techniques
- Maximal preservation of healthy tissues
- New standards in efficiencies for all parties involved
OUR QUALITY POLICY
Our pledge at Catalyst OrthoScience is to deliver the highest quality medical devices that will meet or exceed the expectations of our customers, meet regulatory requirements and demonstrate our commitment to excellence.
As part of this commitment, Catalyst OrthoScience will strive to continually improve the safety and efficacy of our products through an effective quality management system.
JOIN THE TEAM
If you’re ready to help us lead the evolution of shoulder arthroplasty, we’re ready for you.
SEE OPEN POSITIONS
NEWS
Catalyst Fracture System Wins Medical Device Engineering Breakthrough Designation in 2026 MedTech Breakthrough Awards Program
Prestigious International Annual Awards Program Recognizes the Most Innovative Digital Health and Medical Technology Solutions Worldwide NAPLES, Fla., – May 7, 2026 – Catalyst OrthoScience Inc. (“Catalyst”), a private medical technology company redefining shoulder arthroplasty through simplified, surgeon-focused innovation, today announced that the Catalyst Fracture System received the “Medical Device…
Read More
Catalyst OrthoScience Demonstrates Leadership in Procedural Efficiency with Addition of Fracture to Its Single-Tray Portfolio
Celebrating a decade of innovation, the latest technology expands Catalyst’s efficiency-driven approach to shoulder arthroplasty – making it the first and only company in the industry to offer a single-tray portfolio for anatomic, reverse, and fracture procedures NAPLES, Fla., April 16, 2026 - Catalyst OrthoScience Inc. (“Catalyst”), a private medical…
Read More
Catalyst OrthoScience Announces FDA 510(k) Clearance of Archer® Patient-Specific Instrumentation for Shoulder Arthroplasty
New patient-specific solution expands Catalyst’s portfolio, enabling precise translation of 3D surgical plans into the operating room to reduce steps and increase accuracy NAPLES, Fla., Feb. 25, 2026 - Catalyst OrthoScience Inc. (“Catalyst”), a private medical technology company redefining shoulder arthroplasty through simplified, surgeon-focused innovation, today announced U.S. Food…
Read More
1000-0002-A